Rhabdomyolysis after BNT162b2 mRNA Covid-19 vaccine in an adolescent male

Basit Öğe Kaydı
dc.authoridMurat Sütçü / 0000-0002-2078-9796en_US
dc.authoridDoruk Gül / 0000-0003-2558-3719
dc.authoridFatih Atik / 0000-0003-4435-556X
dc.authoridEmine Manolya Kara / 0000-0001-6234-7024
dc.authorscopusidMurat Sütçü / 55499199300en_US
dc.authorscopusidDoruk Gül / 57222108765en_US
dc.authorscopusidFatih Atik / 57789999700en_US
dc.authorscopusidEmine Manolya Kara / 57213122996en_US
dc.authorwosidMurat Sütçü / ABG-7336-2021
dc.authorwosidDoruk Gül / AGJ-2448-2022
dc.authorwosidFatih Atik / FXI-4226-2022
dc.authorwosidEmine Manolya Kara / CXW-4939-2022
dc.contributor.authorSütçü, Murat
dc.contributor.authorGül, Doruk
dc.contributor.authorAtik, Fatih
dc.contributor.authorKara, Emine Manolya
dc.date.accessioned2022-07-19T11:54:38Z
dc.date.available2022-07-19T11:54:38Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractPfizer-BioNTech COVID-19 (BNT162b2) conferred a high level of protection against Covid-19 with a proven short-term safety profile. Although cases of vaccine-associated myopericarditis have been reported, the existence of rhabdomyolysis without myocarditis has not yet been published. A 16-year-old, healthy male patient, who did not use any herbal or illegal drugs before, was admitted with muscle pain that developed after the second dose of BNT162b2 vaccine. Cardiac examination and heart enzymes were normal and the patient had significantly higher creatinine kinase levels. The patient, whose enzymes returned to normal with only force hydration therapy, recovered without complications. Reporting the side effects of the vaccine, which has a short history of application to large populations, is of vital importance in the conduct of vaccine development studies and in identifying the risky group in terms of side effects. © 2022 The College of Medicine and the Medical Association of Malawi.en_US
dc.identifier.citationSutcu, M., Gul, D., Atik, F., & Kara, M. (2022). Rhabdomyolysis after BNT162b2 mRNA covid-19 vaccine in an adolescent male. Malawi Medical Journal, 34(2), 154-156. doi:10.4314/mmj.v34i2.13en_US
dc.identifier.doi10.4314/mmj.v34i2.13en_US
dc.identifier.endpage156en_US
dc.identifier.issn1995-7262en_US
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85133663932en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage154en_US
dc.identifier.urihttps://doi.org/10.4314/mmj.v34i2.13
dc.identifier.urihttps://hdl.handle.net/20.500.12713/3021
dc.identifier.volume34en_US
dc.identifier.wosWOS:000863008400013en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorSütçü, Murat
dc.institutionauthorGül, Doruk
dc.institutionauthorAtik, Fatih
dc.institutionauthorKara, Emine Manolya
dc.language.isoenen_US
dc.publisherMalawi Medical Journalen_US
dc.relation.ispartofMalawi Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAdolescenten_US
dc.subjectPfizer-BioNTech COVID-19en_US
dc.subjectRhabdomyolysisen_US
dc.titleRhabdomyolysis after BNT162b2 mRNA Covid-19 vaccine in an adolescent maleen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Sutcu-2022-Rhabdomyolysis-after-bntb-mrna-covi.pdf
Boyut:
252.5 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu